Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108658851B reveals a safer Suzuki coupling route for cystic fibrosis drug intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced purification technology for Cefsulodin Sodium via acid-base reaction and preparative chromatography. Ensures high purity for pharmaceutical manufacturing and supply chain stability.
Novel synthesis method for fluorescent probes ensures high purity and yield. Ideal for pharmaceutical intermediates manufacturing with reduced cost and scalable supply chain solutions.
Novel Flucytosine synthesis offers high yield and solvent recovery. Ideal for pharmaceutical partners seeking cost reduction and supply chain reliability.
Patent CN103981248B enables high-purity leucine production. Cost-effective enzymatic process ensures supply chain reliability for pharma intermediates.
Novel water-avoidance method improves purity and yield for furbenicillin acid manufacturing ensuring reliable supply chain and significant cost reduction for global buyers
Patent CN119528758A reveals a copper-catalyzed route for alpha-aminoamides. This method offers safer raw materials and streamlined supply chain advantages for pharmaceutical manufacturing.
Novel four-step synthesis of Apoxicillin trihydrate using BTC technology. Delivers high purity, reduced impurities, and scalable manufacturing for reliable pharmaceutical supply chains.
Patent CN105111186A details a novel MTO-catalyzed oxidation route for pantoprazole impurities ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN113461598A details chiral reduction for Benidipine intermediate. Offers high ee value and yield. Enables cost reduction and reliable supply chain for pharmaceutical intermediates manufacturing.
Advanced patent CN103848868B details high-yield tenofovir production ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN108250272A reveals high efficiency separation method ensuring over 99% purity. This breakthrough offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking scalable antifungal production.
Novel enzymatic N-demethylation route for Lesinurad intermediate. High yield, non-toxic reagents, scalable process for API manufacturing.
Patent CN108686687B reveals novel Zn-Pd SiC catalyst for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Discover advanced biocatalytic synthesis for ticagrelor intermediates using engineered ketoreductase. Achieve high substrate loading and cost reduction in pharmaceutical manufacturing.
Novel one-step chlorination-cyclization method for GCLE improves yield and purity while reducing costs for pharmaceutical supply chains globally.
Patent CN120682140A reveals a high-yield fermentation and photocatalytic route for diabetes drug intermediates, offering significant cost and supply chain advantages.
Novel carbonyldiimidazole activation method ensures greater than 99.8 percent purity and cost reduction in API manufacturing for global supply chains.
Patent CN103588838A reveals a novel phosphorylation method for base-modified nucleotides, offering improved selectivity and cost reduction for DNA sequencing reagent manufacturing.
Advanced synthesis of Sulfaclozine Sodium via phase transfer catalysis. Reduces wastewater and improves purity for reliable veterinary drug supply chains.